Increased levels of 4HNE-protein plasma adducts in Rett syndrome.

[1]  G. Valacchi,et al.  Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. , 2010, Toxicology and applied pharmacology.

[2]  H. Forman.  Reactive oxygen species and α,β‐unsaturated aldehydes as second messengers in signal transduction , 2010, Annals of the New York Academy of Sciences.

[3]  G. Valacchi,et al.  Dysfunction of glutathione S-transferase leads to excess 4-hydroxy-2-nonenal and H(2)O(2) and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients. , 2010, Antioxidants & redox signaling.

[4]  S. Scheff,et al.  Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex , 2010, Journal of neuropathology and experimental neurology.

[5]  A. Lojek,et al.  Increased markers of oxidative stress in plasma of patients with chronic pancreatitis. , 2009, Neuro endocrinology letters.

[6]  G. Valacchi,et al.  Systemic oxidative stress in classic Rett syndrome. , 2009, Free radical biology & medicine.

[7]  M. Memo,et al.  Redox proteomics identification of 4‐hydroxynonenal‐modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis , 2009, Proteomics. Clinical applications.

[8]  Alessandra Renieri,et al.  FOXG1 is responsible for the congenital variant of Rett syndrome. , 2008, American journal of human genetics.

[9]  G. Poli,et al.  4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases. , 2008, Molecular aspects of medicine.

[10]  N. Landsberger,et al.  CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. , 2005, Human molecular genetics.

[11]  A. Renieri,et al.  CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms , 2005, Journal of Medical Genetics.

[12]  J. Gécz,et al.  Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. , 2004, American journal of human genetics.

[13]  K. Uchida,et al.  4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. , 2003, Progress in lipid research.

[14]  L. Szweda,et al.  Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. , 1998, Biochemistry.

[15]  T. Montine,et al.  4‐Hydroxy‐2‐Nonenal Pyrrole Adducts in Human Neurodegenerative Disease , 1997, Journal of neuropathology and experimental neurology.

[16]  B. Friguet,et al.  Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. , 1996, Archives of biochemistry and biophysics.

[17]  E. Stadtman,et al.  Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. , 1994, Biochemistry.

[18]  B. Halliwell,et al.  The measurement and mechanism of lipid peroxidation in biological systems. , 1990, Trends in biochemical sciences.

[19]  T. Aw,et al.  The pathophysiological significance of lipid peroxidation in oxidative cell injury , 1987, Hepatology.

[20]  E. Cadenas,et al.  Oxidative stress: damage to intact cells and organs. , 1985, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  A Rett,et al.  [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. , 1966, Wiener medizinische Wochenschrift.

[22]  D. Zimmer,et al.  Lipid oxidation and modification of amyloid-β (Aβ) in vitro and in vivo. , 2010, Journal of Alzheimer's disease : JAD.

[23]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[24]  H. Esterbauer,et al.  Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. , 1990, Methods in enzymology.